Tregs, characterized by FOXP3 expression, are recruited to CRC sites via chemokine signaling and exert immunosuppressive functions by suppressing effector T cell responses and hindering anti-tumor immune surveillance [31]. Here, FOXP3 is linked to colorectal carcinoma.